At Aparito we’re involved in various projects across different study types including the development of novel digital endpoints, hybrid clinical trials and fully decentralised clinical trials.

1. Operationalising
2. Technology in Progress
3. Live Study
4. Completed Study
Technology in Progress
Live Study
Completed Study
Pivotal Regulated Study
Myotonic Dystrophy Type 1
Ataxia Telangiectasia (AT)
Late Onset Pompe Disease (LOPD)
Gaucher Disease – Type 2
MPSIII (Sanfilippo Syndrome)
Ornithine transcarbamylase (OTC) deficiency
Cerebral Cavernous Malformation (CCM)
Osteogenesis Imperfecta
Batten Disease
Hypophosphatemia (XLH)
Angelman Syndrome
Inflammatory disease
Fabry Disease
Incontinence and Soiling
Pre-hab for Gynaecology Surgery
Gaucher Disease – Type 1
Neurodegenerative Disease in Adults
Dystonia (Sleep Quality)
Digital Endpoint Development
Amyotrophic Lateral Sclerosis (ALS)
Pulmonary Arterial Hypertension (PH)
Parkinson’s Disease
SCA & Friedreich’s Ataxia
Primary Ciliary Dyskinesia (PCD)
Duchenne Muscular Dystrophy
Proof of Concept / Feasibility Study
Juvenile Idiopathic Arthritis (JIA)
Niemann-Pick Disease Type C (NPC)
Paediatric Refractory Epilepsy
Leber Congenital Amaurosis (LCA)
Natural History Study
Late Onset GM2 Gangliosidosis
Global Disease Registry
Neuropathic Gaucher Disease

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!